尼氟灭酸通过钙库钙释放引起豚鼠耳蜗螺旋动脉平滑肌细胞超极化(英文)

本研究旨在观察氯离子通道阻断剂尼氟灭酸（niflumic acid,NFA）引起豚鼠耳蜗螺旋动脉平滑肌细胞产生超极化的机制。以豚鼠为实验动物,运用细胞内微电极和全细胞膜片钳记录技术,观察NFA和其它药物对急性分离的耳蜗螺旋动脉平滑肌细胞的作用。结果显示：NFA、indanyloxyacetic acid94（LAh-94）和diSOdium4,4’-diisothiocyanatostilbene-2,2’-disulfonate（DIDS）可使低静息膜电位的细胞产生超极化,但对高静息膜电位的细胞无明显作用。低静息膜电位细胞的平均静息电位为（-42．47±1．38）mV（n=24）,100μmol／LNFA、10μmol／LIAA-94和200μmol／LDIDS分别使细胞超极化至（13．7±4．3）mV=9,P〈0．01）,（11．4±4．2）mV（n=7,P〈0．01）和（12．3±3．7）mV（n=8,P〈0．01）,这种氯离子通道阻断剂引起细胞超极化反应的效应呈浓度依赖性。NFA引起的超极化和外向电流几乎完全被100nmol／L iberiotoxin、100nmol／L charybdotoxin、10mmol／L tetraethylammonium、50μmol／LBAPTA—AM、10μmol／Lryanodine和0．1-10mmol／Lcaffeine阻断,但不能被100μmol／Lnifedipine、100μmol／LCdCI,和无Ca^2＋灌流外液阻断。结果捉示：氯离_了通道的阻断剂NFA可通过平滑肌细胞内钙库的钙释放增加细胞内钙,进而激活钙依赖的钾通道,产生耳蜗螺旋动脉平滑肌细胞的超极化反应。     

乙酰胆碱不依赖NO的释放引起耳蜗螺旋动脉平滑肌细胞的超极化

目的：乙酰胆碱（ACh）不仅是神经递质,也是一种有效的血管舒张物质参与许多血管床的调节活动。本实验观察ACh引起耳蜗螺旋动脉平滑肌细胞超极化的离子机制以及NO在超极化反应中的可能作用。方法：在豚鼠离体耳蜗螺旋动脉标本上,运用细胞内微电极技术记录外源性的ACh引起的反应。结果：在保持灌流液中含有5mmol／L K^＋以及最小纵向张力的情况下,ACh（0．1—10μmol／L）引起低静息膜电位细胞明显的超极化反应,而引起高静息膜电位细胞明显的去极化反应。ACh引起的平滑肌细胞超极化反应是浓度依赖性的（ACh的浓度是1μmol／L和10／μmol／L时,分别引起超极化的幅度是22和30mV,n=7）。ACh引起的超极化反应能被阿托品（atropine,0．1～1μmol／L,n=6）或DAMP（50～100nmol／L,n=6,一种选择性的地受体的拮抗剂）所阻断,同时也可被BAPTA—AM（10μmol／L,n=7,一种可通过细胞膜的Ca^2＋螯合剂）或eharybdotoxin＋apamin（50-100nmol／L,n=4,两种Ca^2＋激活K^＋通道的阻断剂）所阻断,但是Nω-nitro-L-arginine methyl ester（L-NAME,300μmol／L,n=8,一种NO合成酶的完全抑制剂,n≥5）或glipizide（10μmol／L,ATP敏感性的K^＋通道阻断剂,n=4）或indomethacin（10μmol／L,环氧合酶的抑制剂,n=4）不能阻断ACh引起的超极化反应。结论：ACh通过激活内皮细胞的M3受体,开放钙依赖的钾通道．进而引起耳蜗螺旋动脉平滑肌细胞产生超极化反应,并且这一超极化反应与内皮细胞NO的产生和释放无关。     

豚鼠I型前庭毛细胞胆碱能受体通道特性

本文旨在探讨豚鼠I型前庭毛细胞上有无胆碱能受体存在,并对其相应的离子通道特性进行研究。应用全细胞膜片钳技术检测急性分离的豚鼠I型前庭毛细胞对乙酰胆碱（acetylcholine,ACh）的反应。结果显示,7．5％（21／279）的I型前庭毛细胞对10-1000μmol／L ACh敏感,引发明显的外向电流。该电流对ACh的反应呈浓度依赖性,半数激活浓度（EC50）为（63.78±2．31）μmol／L,但该电流为非电压依赖性。在-50mV钳制电压和正常细胞外液中,100μmol／L ACh激活-持久缓慢的外向电流,电流幅值为（170±15）pA,该电流幅值依赖于胞外钙离子浓度,可被胞外给予的钙依赖性钾通道拮抗剂TEA阻断。I型前庭毛细胞的再次激活时间不小于1min。长时间暴露在ACh的情况下,受体离子通道不会发生自发性关闭。以上结果提示,部分豚鼠I型前庭毛细胞上存在胆碱能受体,胞外给予ACh可激活-持久缓慢的外向电流,其胆碱能受体通道对于ACh的作用呈浓度依赖性和外钙依赖性、非电压依赖性或失敏性。本研究结果对于阐明前庭传出神经的功能及其作用机制,证实并揭示I型前庭毛细胞上存在传出神经递质受体以及日后临床指导眩晕疾病的康复治疗具有重要的意义。     

库容性Ca2+内流参与ACh诱导的大鼠远端结肠平滑肌收缩

应用生物换能技术和Ca^2＋通道特异性阻断剂观察并记录大鼠离体远端结肠平滑肌收缩张力的变化,分析库容性Ca^2＋内流（capacitative Ca^2＋ entry,CCE）是否与ACh诱导的离体远端结肠平滑肌收缩反应有关。结果表明,以无钙的Krebs液灌流或应用EGTA螯合细胞外Ca^2＋后,高K^＋及ACh引起的远端结肠平滑肌收缩几乎完全消失。电压操纵性Ca^2＋通道阻断剂verapamil也能减弱高K^＋及ACh引起的远端结肠平滑肌收缩,其减弱的程度分别为74％和41％。在无钙的Krebs液中,5μmol／LACh可引起离体肠管瞬时性收缩,这是由肌质网（sarcoplasmic reticulum,SR）释放钙所致：然后加入10μmol／L阿托品（atropine）,并在此基础上恢复细胞外Ca^2＋（2．5mmol／L）,结肠平滑肌则出现持续性收缩,待收缩反应达峰值时,加入5μmol／L verapamil,收缩无明显变化,且该收缩反应对钙库操纵性通道（store-operated Ca^2＋ channel,socc）阻断剂La^3＋敏感,20,50和100μmol／L的La^3＋使上述收缩张力分别降低15％,23％和36％,且呈浓度依赖性,但对Cd^2＋不敏感。研究结果提示,细胞外Ca^2＋内流对高K^＋及ACh介导的离体远端结肠平滑肌持续性收缩是必需的,由ACh诱导的远端结肠平滑肌收缩至少包括SR释放钙引起的短暂性收缩及受体操纵性Ca^2＋通道（receptor-operated Ca^2＋ channel,ROCC）、电压操纵性Ca^2＋通道（voltage-operated Ca^2＋ channel,VOCC）和CCE介导的胞外Ca^2＋ 内流等途径。这将从通道水平进一步分析消化管平滑肌收缩的机制和特征,亦将为预防和控制因胃肠动力紊乱所致的消化管疾病寻求有针对性的药物干预和治疗提供理论依据。     

持续癫痫样放电导致海马神经元钙离子动力学变化的研究

目的：研究低镁介质致痫的培养海马神经元癫痫模型中神经元内游离钙离子（[Ca^2＋]i）的时空分布及其动力学改变,以探讨钙离子在癫痫发病过程中的作用。方法：联合应用共聚焦激光扫描显微镜和膜片钳,运用较高时间分辨率动态观察培养海马神经元癫痫模型[Ca^2＋]i和电生理变化,以及化学门控钙离子通道阻滞剂的影响。结果：致痫后海马神经元胞浆和核内游离钙离子迅速上升到（612±65）nmol／L和（620±69）nmol／L水平,NMDA受体阻断剂MK-801（10μmol／L）和非NMDA受体阻断剂NBQX（10μmol／L）可使[Ca^2＋]i的升高明显减少;升高的[Ca^2＋]i恢复有明显的延迟现象,90min和150min癫痫样放电后[Ca^2＋]i恢复的时间分别为（114．8±5．2）和（135．0±22．7）（P〈0．05）。结论：持续的癫痫样放电可导致海马神经元细胞内钙超载,这个效应可被MK-801阻断,化学门控钙离子通道也参与了细胞外Ca^2＋内流的过程。     

一氧化氮对大鼠背根神经节神经元膜电位的作用

目的：观察一氧化氮对大鼠背根神经节神经元的作用及有关离子机制,并探讨一氧化氮在痛觉信息传递过程中的作用。方法：在分离的大鼠背根神经节标本上,应用细胞内记录技术,给予灌流一氧化氮供体硝普钠,观察硝普钠诱导的神经元膜反应。结果：大部分神经元对硝普钠敏感（79／102,77．45％）,滴加硝普钠（10～100mmol／L）后可引起浓度依赖性的超极化反应,剩余神经元没有反应。硝普钠（100mmol／L）可使神经元膜电导由（21．06±1．94）nS增加到（23．08±0．92）nS。L-NAME（非选择性一氧化氮合酶抑制剂,1mmol／L）、CdCl2（非选择性钙通道阻断剂,0．1mmol／L）、无Na^＋平衡盐液对硝普钠引起超极化反应无明显影响。四乙基碘化铵（非选择性钾通道阻断剂,10mmol／L）明显抑制硝普钠引起的超极化反应。结论：硝普钠在大鼠背根神经节神经元上可引起浓度依赖的超极化反应,且此超极化反应是钾电导介导的。     

氯离子通道阻断剂对豚鼠耳蜗螺旋动脉平滑肌细胞兴奋性接头电位的影响

血管平滑肌细胞膜上存在氯离子通道,不仅参与调节平滑肌细胞的肌原性紧张,而且参与多种血管床的神经平滑肌细胞之间的信息传递,但氯离子通道及其阻断剂对耳蜗螺旋动脉（spiral modiol arartery,SMA）平滑肌细胞兴奋性接头电位（excitatory junction potential,EJP）是否有影响,尚不清楚。本实验运用细胞内微电极记录技术,在豚鼠耳蜗SMA离体标本上,研究氯通道阻断剂（niflumic acid,NFA,indanyloxyacetic acid 94,IAA-94;disodium 4,4’-diisothiocyanatostilbene-2．2’-disulfonate,DIDS）对去甲肾上腺素（norepinephrine,NE）引起SMA平滑肌细胞去极化反应和平滑肌细胞EJP的影响。结果显示,多数SMA平滑肌细胞在适宜的刺激下,通过神经兴奋传递产生EJP（75％,n=49）。在联合使用α1（prazosin,0．1-1 μmol／L）,α2（idazoxan,0．3-1μmol／L）和P2x（PPADS,10-100μmol／L）受体拮抗剂时,所产生的EJP幅值仅有30％-80％被抑制。在使用上述拮抗剂的基础上,NFA（10-1000μmol/L）能进一步抑制EJP,而且缩短EJP的时程。减少细胞外氯离子浓度（由135．6mmol／L减少到60mmol／L）,在同样刺激强度下激起的EJP的幅度和时程均增加,低氯的这一作用可被IAA-94和DIDS所反转。NFA和IAA-94也可进一步抑制α1、α2和β受体拮抗剂联合使用不能消除的NE（1—50μmol／L）引起的去极化反应。结果提示：NE可能通过激活一类非α、非β肾上腺能受体（可能属于γ肾上腺能受体）引起氯离子通道开放,增加氯离子电导,调节耳蜗SMA平滑肌细胞的生理活动。     

氨甲酰胆碱通过M2胆碱能受体对大鼠心肌细胞发挥正性肌力作用

为研究氨甲酰胆碱（carbachol,CCh）对大鼠心肌细胞的正性肌力作用机制,利用电压钳方法观察CCh对急性分离的单个大鼠心肌细胞L-型钙电流（足扎）和钠,钙交换电流（INa/Ca）的影响。细胞负载Fura-2／AM后,用离子成像系统测定场刺激下单个大鼠心肌细胞的钙瞬变和细胞缩短。结果表明,100ILmol／LCCh使正向INa/Ca从（1．18±0．57）pA／pF增加到（1．65±0．52）pA/pF（P〈O．01）,反向,INa/Ca从（1．11±0．49）pA/pF增加到（1．53±0．52）pA/pF（P〈O．01）,但不影响ICa,L。阿托品（非选择性M胆碱受体拮抗剂）和methoctramine（选择性M2胆碱受体拮抗剂）可阻断这种增加作用。100μmol／LCCh使钙瞬变从对照组的203．8±50．0增加到234．8±64.3,使细胞缩短从对照组的（3．00±0．67）μm增加到（3．55±1．21）μm。KB-R7943（选择性反向INa/Ca抑制剂）不影响钙瞬变和细胞缩短的基础水平,却完全阻断CCh引起的钙瞬变和细胞缩短的增加。尼卡地平（ICa,L抑制剂）抑制钙瞬变和细胞缩短。CCh在尼卡地平存在下仍可增加钙瞬变和细胞缩短值,提示其正性肌力作用是通过刺激钠,钙交换实现的。CCh不改变钙敏感性。阿托品和methoctramine阻断CCh的这种激动作用,说明CCh的正性肌力作用是通过M2受体实现的。以上结果提示,CCh对大鼠心肌细胞有正性肌力作用,这种作用是通过激动反向钠／钙交换实现,由M2受体介导。     

钾通道在大鼠支气管平滑肌张力调控中作用的研究

目的：探讨延迟整流钾通道（Kv),高电导钙激活钾通道（BKCa)和ATP敏感钾通道（KATP)在大鼠支气管平滑肌张力调控中的作用。方法：以特异性钾通道阻断剂为工具,采用体外等长张力测定观察钾通道对静息和收缩状态下支气管张力的影响。结果：（1）KV阻断剂4－aminopyridine(4-AP)诱发大鼠支气管平滑肌产生浓度依赖性收缩反应,而BKCa阻断剂tetraethylammonium(TEA)和KATP阻断剂glibenclamide(Glib)对其无影响。（2）去除上皮对4－AP诱发大鼠支气管平滑肌收缩反应无影响,而钙通道阻断剂nifedipine对其有显著抑制效应。（3）在0.1mmol/L组胺或50mmol/L KCl诱发支气管平滑肌收缩之前或之后,加入TEA（1,5mmol/L)或0.1mmol/L 4-AP均显著增强二者诱发的收缩反应;而Glib(10μmol/L）对其无明显影响。结论：Kv参与大鼠支气管平滑肌静息张力的调控,而BKCa和KATP对其无影响。Kv和BKCa的关闭增强组胺及高浓度钾离子诱发大鼠离体支气管产生的收缩张力。     

乙酰胆碱对蟾蜍背根神经节神经元膜电位的影响及离子机制

在离体灌流的蟾蜍背根神经节(DRG)标本上,用微电极进行胞内记录。在73个神经元中,依神经纤维的传导速度将神经元分为 A 型及 C 型,其中 A 型细胞67个,C 型6个,静息膜电位为-67.5±1.3mV((?)±SE)。当加4×10~(-4)—6×10~(-4)mol/L 乙酰胆碱(ACh),可观察到如下四种膜电位变化:1.超极化:幅值9.1±3.0mV((?)±SE,n=23);(2)去极化:幅值12.9±2.2mV((?)+SE,n=20);(3)双相反应(n=24):先超极化,后去极化,超极化幅值8.0±2.4mV((?)+SE),去极化幅值10.9±3.1mV((?)±SE);(4)无反应(n=6)。用阿托品(1.3×10~(-5)mol/L,n=23),或同时应用筒箭毒与六甲双铵(浓度均为1.4×10~(-5)mol/L,n=8)灌流,能分别阻断 ACh 引起的膜的超极化或去极化。ACh 引起超极化反应时膜电导平均增加13.8%,翻转电位值大约-96mV。四乙铵(TEA,20mmol/L)能使 ACh 的去极化幅值增加48.2±3.2%((?)±SE,n=6),超极化幅值减小79.4±4.3%((?)±SE,n=8)。MnCl_2(4mmol/L)使 ACh 的去极化及超极化幅值分别减小54.2±7.2%((?)±SE,n=5)及69.2±6.4%((?)±SE,n=14)。以上结果提示:ACh 引起的 DRG 神经细胞膜去极化反应由 N 型乙酰胆碱受体介导,而超极化反应由 Μ 型乙酰胆碱受体介导,前者可能包含了多种离子电导的改变,后者则可能与钾电导增加有关。     

Leukotriene and purinergic receptors are involved in the hyperpolarizing effect of glucagon in liver cells

The pancreatic hormone glucagon hyperpolarizes the liver cell membrane. In the present study, we investigated the cellular signalling pathway of glucagon-induced hyperpolarization of liver cells by using the conventional microelectrode method. The membrane potential was recorded in superficial liver cells of superfused mouse liver slices. In the presence of the K+ channel blockers tetraethylammonium (TEA, 1 mmol/l) and Ba2+ (BaCl2, 5 mmol/l) and the blocker of the Na+/K+ ATPase, ouabain (1 mmol/l), no glucagon-induced hyperpolarization was observed confirming previous findings. The hyperpolarizing effect of glucagon was abolished by the leukotriene B4 receptor antagonist CP 195543 (0.1 mmol/l) and the purinergic receptor antagonist PPADS (5 micromol/l). ATPgammaS (10 micromol/l), a non-hydrolyzable ATP analogue, induced a hyperpolarization of the liver cell membrane similar to glucagon. U 73122 (1 micromol/l), a blocker of phospholipase C, prevented both the glucagon- and ATPgammaS-induced hyperpolarization. These findings suggest that glucagon affects the hepatic membrane potential partly by inducing the formation and release of leukotrienes and release of ATP acting on purinergic receptors of the liver cell membrane.     

Electrophysiological responses of crayfish oocytes to biogenic amines

Intracellular recordings were made from immature, growing oocytes of the crayfish Pacifastacus leniusciulus. Oocytes had a relatively negative resting potential of -74.7+/-2.2 mV (n=26; range -53 to -90) and a mean input resistance of 0.86+/-0.19 MOmega (n=22; range 0.17-3.3). Octopamine induced a long-lasting response involving biphasic changes in input resistance, together with bi- or multiphasic changes in membrane potential. The resistance-decreasing phase involved (in different oocytes) membrane hyperpolarization, depolarization or both. The resistance-increasing phase was usually a depolarization. The hyperpolarizing form of the resistance-decreasing response, and the depolarizing resistance-increasing response reversed in polarity at membrane potentials of (respectively) -90 and -92 mV, suggesting increases and decreases in K(+) conductance underly the biphasic changes in input resistance. The threshold concentration for the response was remarkably low (>10(-12) M) and showed little or no dose-dependence over the concentration range 10(-12)-10(-6) M. Similar responses were evoked by dopamine and serotonin (at 10(-9) M), although a higher proportion of oocytes responded to octopamine and/or dopamine than to serotonin.     

Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes

KCNQ2 and KCNQ3 subunits encode for the muscarinic-regulated current (I(KM)), a sub-threshold voltage-dependent K+ current regulating neuronal excitability. In this study, we have investigated the involvement of I(KM) in dopamine (DA) release from rat striatal synaptosomes evoked by elevated extracellular K+ concentrations ([K+]e) and by muscarinic receptor activation. [3H]dopamine ([3H]DA) release triggered by 9 mmol/L [K+]e was inhibited by the I(KM) activator retigabine (0.01-30 micromol/L; Emax = 54.80 +/- 3.85%; IC50 = 0.50 +/- 0.36 micromol/L). The I(KM) blockers tetraethylammonium (0.1-3 mmol/L) and XE-991 (0.1-30 micromol/L) enhanced K+-evoked [3H]DA release and prevented retigabine-induced inhibition of depolarization-evoked [3H]DA release. Retigabine-induced inhibition of K+-evoked [3H]DA release was also abolished by synaptosomal entrapment of blocking anti-KCNQ2 polyclonal antibodies, an effect prevented by antibody pre-absorption with the KCNQ2 immunizing peptide. Furthermore, the cholinergic agonist oxotremorine (OXO) (1-300 micromol/L) potentiated 9 mmol/L [K+]e-evoked [3H]DA release (Emax = 155 +/- 9.50%; EC50 = 25 +/- 1.80 micromol/L). OXO (100 micromol/L)-induced [3H]DA release enhancement was competitively inhibited by pirenzepine (1-10 nmol/L) and abolished by the M3-preferring antagonist 4-diphenylacetoxy N-methylpiperidine methiodide (1 micromol/L), but was unaffected by the M1-selective antagonist MT-7 (10-100 nmol/L) or by Pertussis toxin (1.5-3 microg/mL), which uncouples M2- and M4-mediated responses. Finally, OXO-induced potentiation of depolarization-induced [3H]DA release was not additive to that produced by XE-991 (10 micromol/L), was unaffected by retigabine (10 micromol/L), and was abolished by synaptosomal entrapment of anti-KCNQ2 antibodies. Collectively, these findings indicate that, in rat striatal nerve endings, I(KM) channels containing KCNQ2 subunits regulate depolarization-induced DA release and that I(KM) suppression is involved in the reinforcement of depolarization-induced DA release triggered by the activation of pre-synaptic muscarinic heteroreceptors.     

Actions of acetylcholine on the salivary gland cells of the pond snail, Planorbis corneus

Intracellular recordings have been made from salivary gland cells of the pond snail Planorbis corneus. Gland cells produced a dose-dependent biphasic response to the bath application of acetylcholine (ACh), an initial depolarization being followed by a hyperpolarization. Nicotine and the nicotinic agonist tetramethylammonium had an excitatory action on the gland cells. The muscarinic agonists acetyl-beta-methyl choline and arecoline were also stimulants, but muscarine, bethanechol and pilocarpine produced no response from gland cells at 10(-3) M. A number of cholinergic antagonists, including atropine, hexamethonium and curare, effectively blocked the response to ACh. The depolarizing phase of the ACh response resulted from an increased membrane permeability to Na+ ions, though the participation of other ionic species cannot be ruled out. The hyperpolarizing phase of the ACh response was produced by the activity of an electrogenic Na+/K+ pump.     

Subacute reserpine treatment reveals preferential coupling between the M3 muscarinic receptor subtype and phosphatidylinositol turnover.

Muscarinic receptors in the rat cerebral cortex, cardiac atria and vas deferens were identified, quantitated, and characterized relative to phosphatidylinositol (PI) turnover as the functional response to stimulation of specific receptor subtypes. Receptor densities as determined by 3H-QNB binding were ranked: cerebral cortex greater than vas deferens greater than heart. Using displacement of 3H-QNB binding by the selective M1 and M2 muscarinic receptor antagonists pirenzepine and 11[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro- 6H-pyrido [2,3-b] [1,4] benzodiazepine-6-one (AF-DX 116) respectively, heterogeneous populations were found in the cerebral cortex and vas deferens. The M1 receptor subtype predominated in the former and the M2 predominated in the latter. An homogeneous M2 receptor population was present in the heart. Methacholine-stimulated accumulation of 3H inositol-1-phosphate was greater in the vas deferens than in the cerebral cortex, whereas PI turnover was not enhanced in cardiac atria. Reserpine treatment of rats (0.5 mg kg-1 day-1 for 7 days) increased muscarinic receptor density in the vas deferens coincident with a shift in the low affinity pKi for AF-DX 116 to a value comparable to high affinity binding, and abolished the enhanced PI hydrolysis. In the cerebral cortex, reserpine treatment shifted only the early portion of the methacholine dose-response curve to the right. These results are judged to be supportive of preferential coupling between the M3 muscarinic receptor subtype and PI turnover.     

EDHF contributes to strain-related differences in pulmonary arterial relaxation in rats

Pulmonary arteries from the Madison (M) strain relax more in response to acetylcholine (ACh) than those from the Hilltop (H) strain of Sprague-Dawley rats. We hypothesized that differences in endothelial nitric oxide (NO) synthase (eNOS) expression and function, metabolism of ACh by cholinesterases, release of prostacyclin, or endothelium-derived hyperpolarizing factor(s) (EDHF) from the endothelium would explain the differences in the relaxation response to ACh in isolated pulmonary arteries. eNOS mRNA and protein levels as well as the NO-dependent relaxation responses to thapsigargin in phenylephrine (10(-6) M)-precontracted pulmonary arteries from the M and H strains were identical. The greater relaxation response to ACh in M compared with H rats was also observed with carbachol, a cholinesterase-resistant analog of ACh, a response that was not modified by pretreatment with meclofenamate (10(-5) M). N(omega)-nitro-L-arginine (10(-4) M) completely abolished carbachol-induced relaxation in H rat pulmonary arteries but not in M rat pulmonary arteries. Precontraction with KCl (20 mM) blunted the relaxation response to carbachol in M rat pulmonary arteries and eliminated differences between the M and H rat pulmonary arteries. NO-independent relaxation present in the M rat pulmonary arteries was significantly reduced by 17-octadecynoic acid (2 microM) and was completely abolished by charybdotoxin plus apamin (100 nM each). These findings suggest that EDHF, but not NO, contributes to the strain-related differences in pulmonary artery reactivity. Also, EDHF may be a metabolite of cytochrome P-450 that activates Ca(2+)-dependent K(+) channels.     

Inositol trisphosphate-induced hyperpolarization in rat dorsal root ganglion neurons.

Inositol 1,4,5-trisphosphate (1,4,5-InsP3) was perfused into rat dorsal root ganglion (DRG) neurons by whole-cell patch-clamp electrodes, while measuring the membrane potential. This operation evoked a transient (2-3 min) membrane hyperpolarization of about -15 mV (from -42 mV) followed by a depolarization. The membrane hyperpolarization was abolished when 30 mM EGTA was perfused together with 1,4,5-InsP3 or when 0.2 mM quinine was added to the bath solution. The hyperpolarizing response was enhanced when a low-Ca2+ EGTA-free intracellular solution was used. Two InsP2 isomers induced a different response. Our results suggest that the hyperpolarization is due to 1,4,5-InsP3-induced Ca2+ release which may trigger Ca-sensitive K+ channels to open. Present results show that cultured DRG neurons are able to respond to 1,4,5-InsP3 perfusion in the whole-cell configuration.     

Regional heterogeneity in acetylcholine-induced relaxation in rat vascular bed: role of calcium-activated K+ channels

Ca+ -activated K+ -channels (KCa) regulate vasomotor tone via smooth muscle hyperpolarization and relaxation. The relative contribution of the endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation differs depending on vessel type and size. It is unknown whether these KCa channels are differentially distributed along the same vascular bed and hence have different roles in mediating the EDHF response. We therefore assessed the role of small- (SKCa), intermediate- (IKCa), and large-conductance (BKCa) channels in mediating acetylcholine-induced relaxations in both first- and fourth-order side branches of the rat superior mesenteric artery (MA1 and MA4, respectively). Two-millimeter segments of each MA were mounted in the wire myograph, incubated with Nomega-nitro-L-arginine methyl ester (L-NAME, 100 micromol/l) and indomethacin (10 micromol/l), and precontracted with phenylephrine (10 micromol/l). Cumulative concentration-response curves to ACh (0.001-10 micromol/l) were performed in the absence or presence of selective KCa channel antagonists. Apamin almost completely abolished these relaxations in MA4 but only partially blocked relaxations in MA1. The selective IKCa channel blocker 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) caused a significantly greater inhibition of the ACh-induced relaxation in MA4 compared with MA1. Iberiotoxin had no inhibitory effect in MA4 but blunted relaxation in MA1. Relative mRNA expression levels of SKCa (rSK1, rSK3, and rSK4 = rIK1) were significantly higher in MA4 compared with MA1. BKCa (rBKalpha1 and rBKbeta1) genes were similar in both MA1 and MA4. Our data demonstrate regional heterogeneity in SKCa and IKCa function and gene expression and stress the importance of these channels in smaller resistance-sized arteries, where the role of EDHF is more pronounced.